ETBX-021
UNII S4MK9TOL0D

Substance Identification & Data

This profile provides standardized clinical and technical data for Etbx-021, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S4MK9TOL0D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2171509-20-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S4MK9TOL0D

CAS Registry Number

2171509-20-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETBX-021

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C150517

National Cancer Institute reference terminology for clinical and research data.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

NCBI Taxonomy

28285

Unique numeric identifier used to specify biological species in the NCBI database.

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Etbx-021. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

A HER2 PROTEIN-TARGETING ADENOVIRUS VECTOR BREAST CANCER VACCINE COMPRISED OF THE (AD5 (E1-, E2B-)-HER2/NEU) VECTOR MODIFIED BY REMOVAL OF THE E1, E2B AND E3 GENES AND INSERTION OF A MODIFIED HER2/NEU GENE

AD5 (E1-, E2B-)-HER2/NEU VACCINE ETBX-021

ETBX-021

External Clinical & Regulatory Resources

Previous UNIIS4M959U2IJ

Next UNIIS4N226VUZH